baber/WOPTO huggingface dataset:
Patent CA-2491410-A1 (CA)
Inventor: XIONG WEI
IPC: H04B17/00
Filed: 2003-06-28
Abstract: A method of self-calibration of a wireless LAN communication device includes entering a self-calibration mode when the device is powered up or commanded by software. A packet stream is transmitted at an initial transmit power level.  The packet stream may comprise standard data packets. The transmit power level may be monitored from data packet to data packet; and adjusted in steps by setting a transmit gain using a control voltage adjustment determined according to a transmit gain variation so as to make the step size as large as possible without exceeding a predetermined maximum step size. The transmit power level is, thus, adjusted so as not to exceed a predetermined maximum allowable level. The transmit power level is then adjusted to a desired level.  Lower desired transmit power levels may be set by shifting bits in a digital-to-analog converter and setting the transmit gain for a higher transmit power level.
Patent CA-2491452-A1 (CA)
Title: Mold-removal casting method and apparatus
Inventor: CAMPBELL JOHN
IPC: B22D30/00
Filed: 2003-07-09
Abstract: A process for the casting of metals includes the steps of providing a mold, delivering a molten metal into the mold, solidifying the molten metal, and removing at least a portion of the mold. The step of removing at least a portion of the mold begins before the step of solidifying the molten metal h as been finished. An apparatus to deliver a solvent to a mold is also provided.
Patent CA-2491587-A1 (CA)
Inventor: WEYERSHAUSEN BERND
IPC: C08K5/16
Filed: 2003-06-13
Abstract: The invention relates to a polymeric composition which contains a polymer which is crystalline without ionic group and at least one component exhibiti ng a plasticising property. The plasticiser of said polymeric composition is embodied in the form of an ionic liquid whose content ranges from 0.1 to 30 mass %. The inventive method for producing and using the polymeric compositi on is also disclosed.
Patent CA-2495907-A1 (CA)
Title: System and method of personalizing an out-of-home experience
Inventor: ROOS LARRY
IPC: G06Q10/02
Filed: 2003-08-20
Abstract: Published without an Abstract
Patent CA-2496296-A1 (CA)
Inventor: MOON JOHN
IPC: G02B5/18
Filed: 2003-08-20
Abstract: Microparticles (8) includes an optical substrate (10) having at least one diffraction grating (12) disposed therein. The grating (12) having a plurality of colocated pitches .LAMBDA. which represent a unique identification digital code that is detected when illuminated by incident light (24). The incident light (24) may be directed transversely from the side of the substrate (10) with a narrow band (single wavelength) or multiple wavelength source, in which case the code is represented by a spatial distribution of light or a wavelength spectrum, respectively. The code may be digital binary or may be other numerical bases. The micro-particles (8) can provide a large number of unique codes, e.g., greater than 67 million codes, and can withstand harsh environments. The micro~particles (8) are functionalized by coating them with a material/substance of interest, which are then used to perform multiplexed experiments involving chemical processes, e.g., DNA testing and combinatorial chemistry.
Patent CA-2496894-A1 (CA)
Title: Quantum circuit and quantum computer
Inventor: TOMITA AKIHISA
IPC: G06F17/14
Filed: 2002-10-02
Abstract: A quantum circuit and a quantum computer capable of performing the multi-bit quantum computation. Control unitary conversion is realized by indicating the quantum bit by the optical polarization direction, successively inputting the polarized optical pulse row indicating the row of the quantum bit, and determining the magnitude of the polarizing rotation and the phase difference functioning on a certain optical pulse according to the measurement result of the polarization of the previously input optical pulse row. The effect of errors is reduced by setting the number of photons included in one pulse to be larger than 1 in the optical pulse indicating the quantum bit.
Patent CA-2498398-A1 (CA)
Title: Method and apparatus for extrusion coating of fluorescent light tubes
Inventor: CANNON MARK
IPC: H01J9/46
Filed: 2003-09-09
Abstract: A method and apparatus (40) for coating the glass envelope (13) and portions of the end caps (11) of fluorescent light tubes (15) in a continuous and sequential manner with a thermo~plastic material. The coating is applied by a cross head extruder (65) through which the light tubes (15) are sequentially fed. A vacuum applied during the coating process promotes direct and intimat e contact between the coating and the light tubes (15). The end caps (11) may be heated prior to coating to ensure adherence of the coating to the end caps (11) and not to the glass envelope (13). Post-coating processes include cooling the coating, severing individual light tubes (15) from the chain of sequentially coated light tubes (15), and readying the coated light tubes (1 5) for packaging. The method is automatic, with the apparatus (40) being automatically controlled by a control unit (100).
Patent CA-2501349-A1 (CA)
Inventor: KLOTZ KEVIN
IPC: C04B41/85
Filed: 2003-10-07
Abstract: A coating process comprising: (A) applying to a surface, for example, a metallic surface, a coating compositions consisting essentially of an alkali metal silicate and an aqueous liquid phase having dispersed therein solid aluminum particles to form on the surface a wet coating; and (B) drying said wet coating : (I) under conditions which convert said wet coating to an electrically conductive, corrosion-resistant, solid coating; or (ii) under conditions which form a solid coating which is not electrically conductive (non-conductive) and thereafter treating said non-conductive coating under conditions which convert said non-conductive coating to an electrically conductive, corrosion-resistant coating compositions for use in the process, and the provision of highly corrosion-resistant coated articles.
Patent CA-2501647-A1 (CA)
Title: High frequency high frame-rate ultrasound imaging system
Inventor: MEHI JAMES I
IPC: G01S15/89
Filed: 2003-10-10
Abstract: A system for producing an ultrasound image comprises a scan head (106) havin g a transducer (124) capable of generating ultrasound energy at a frequency of at least 20 megahertz (MHz), and a processor (134) for receiving ultrasound energy and for generating an ultrasound image (116) at a frame rate of at least 15 frames per second (fps).
Patent CA-2506914-A1 (CA)
Inventor: ZHANG HONGXING
IPC: H04L69/40
Filed: 2003-08-13
Abstract: The present invention discloses a method for implementing link state passing-through in network, for informing the peer of link fault, said method comprising the following steps: the service device detecting whether there is a link fault in the network; in case of link fault, the service device transferring link fault information to peer service device with a control frame; in response to said control frame containing link fault information, the peer service device disconnecting the user's link and performing corresponding processes; the user at the faulty peer communicating with peer user through the spare network; when said link recovers to normal, the service device at the recovery peer sending a control frame containing link fault recovery information to peer service device to reestablish communication between said users on said link. The present invention is capable of informing the peer of link fault and reducing extra overhead under normal network conditions as much as possible.
Patent CA-2507388-A1 (CA)
Inventor: SIMARD REGIS
IPC: C02F1/52
Filed: 2003-11-28
Abstract: L'invention concerne de manière générale un procédé de traitement de lisier d'animaux domestiques, p. ex. porcs et cochons, visant à rendre ledit lisier écologiquement acceptable. Elle concerne plus particulièrement un procédé de déphosphatation de lisier, qui comporte les étapes consistant à : 1) ajouter des sous-produits d'électrolyse et de fonderie (BPEF) au lisier liquide ; 2) mélanger le BPEF contenant le lisier ; 3) laisser reposer le BPEF mélangé et contenant le lisier pendant une durée suffisante pour que le lisier se sépare en une fraction solide et une fraction liquide, la fraction solide se déposant dans la fosse à lisier ; et 4) séparer les fractions liquide et solide. La fraction liquide contient moins de 50 % du phosphore total contenu initialement dans le lisier, le phosphore se trouvant dans la fraction solide.
Patent CA-2510336-A1 (CA)
Title: Balanced continuous well string injection unit
Inventor: KULHANEK EMANUEL
IPC: E21B19/00
Filed: 2005-05-26
Abstract: A continuous well string injection unit and balancing system, in which the continuous well string injection unit is suspended using a sling connected to a pair of suspension points. The balancing system comprises a length-adjustable member connected to the rod injector at a third suspension point, and a controller for adjusting the length of the length-adjustable member.
Patent CA-2511530-A1 (CA)
Title: Night-time oral insulin therapy
Inventor: GOLDBERG MICHAEL
IPC: A61K/
Filed: 2004-01-06
Abstract: A method for protection of a mammal that has impaired glucose tolerance or early stage diabetes mellitus from developing overt or insulin dependent diabetes comprises administering an orally effective dose of a pharmaceutical formulation comprising insulin at nighttime, e.g., at or shortly before bedtime.
Patent CA-2518047-A1 (CA)
Title: Method for controlling oxygen when separating minerals from a slurry
Inventor: LAURILA HEIKKI
IPC: C22B15/00
Filed: 2004-03-10
Abstract: The invention relates to a method for controlling the partial pressure of oxygen when mutually separating minerals in the different process steps of the separation process. In order to control the partial pressure of oxygen, the gases fed in the different process steps are recirculated in an essentially closed gas circulation created around the equipment used in the different process steps, so that the gas recirculation is controlled by measuring the potential of the slurry containing valuable minerals.
Patent CA-2518836-A1 (CA)
Inventor: BOEHM MARCUS F
IPC: A61K9/107
Filed: 2003-10-04
Abstract: Drug formulations having emulsifying agents and both medium and long chain triglycerides are described. In preferred embodiments, the long chain triglycerides negate or lessen deleterious central nervous system effects that are caused by medium chain triglycerides.
Patent CA-2518872-A1 (CA)
Title: Devices, methods, and compositions to prevent restenosis
Inventor: JOHNSON ROBERT G JR
IPC: A61F2/06
Filed: 2004-03-29
Abstract: Medical devices, compositions and methods to prevent or reduce restenosis using epothilones, geldanamycin analogs, and rapamycin or rapamycin analogs alone or in synergistic combinations.
Patent CA-2520005-A1 (CA)
Title: A load carrying vehicle
Inventor: LONG MARK JAMES
IPC: B60P7/15
Filed: 2004-03-19
Abstract: The invention relates to a load carrying vehicle of the type that has a body forming a load carrying compartment (16) above a load deck (17), and where the load carrying compartment (16) is of the side loading type. The vehicle has a load carrying structure located in its load carrying compartment, the load carrying structure including a platform support structure that is located along the length of the load carrying compartment (16) along the centre line of the load deck (17). The platform support structure includes support formations that provide for the support of load platforms (42) of the load carrying structure, on which loads can be supported, at different levels above the two side halves of the load deck. The mode of support permits easy manual adjustment of the level of individual load platforms above the load deck.
Patent CA-2521448-A1 (CA)
Inventor: BEYER JURGEN
IPC: H04W24/00
Filed: 2004-04-02
Abstract: Procédé d'analyse de la situation d'interférence et de mise à disposition dans des sous-réseaux UMTS (Universal Mobile Telecommunication System). Selon la présente invention, il est possible de déterminer des rapports de mise à disposition pour chaque service dans le sous-réseau considéré à l'aide de données de mesure qui sont enregistrées soient en l'absence, soit en présence d'une charge de trafic du réseau.
Patent CA-2522404-A1 (CA)
Title: One or several enzyme-containing compounds, dietetic food products and drugs produced from said compounds and the use therefor for medical purposes
Inventor: MILLER WINFRIED
IPC: A23L1/30
Filed: 2004-05-14
Abstract: The invention relates to one or several enzyme-containing compounds, i.e. to one or several hydrolyses and to one or several antioxidants which are selected from ubiquinones, carotinoides and antioxidative vitamins. The inventive compounds are used in the form of components for producing food products or drugs which are used, inter alia as dietetic food supplements, in particular for a supplementary dietetic regime and for treating immune system disorders.
Patent CA-2526556-A1 (CA)
Title: Stable radiopharmaceutical compositions and methods for their preparation
Inventor: TWEEDLE MICHAEL
IPC: A61K/
Filed: 2004-07-23
Abstract: Stabilized radiopharmaceutical formulations are disclosed. Methods of making and using stabilized radiopharmaceutical formulations are also disclosed. The invention relates to stabilizers that improve the radiostability of radiotherapeutic and radiodiagnostic compounds, and formulations containing them. In particular, it relates to stabilizers useful in the preparation and stabilization of targeted radiodiagnostic and radiotherapeutic compounds, and, in a preferred embodiment, to the preparation and stabilization of radiodiagnostic and radiotherapeutic compounds that are targeted to the Gastrin Releasing Peptide Receptor (GRP-Receptor).
Patent CA-2529332-A1 (CA)
Title: Method of preparing cis-8b-methyldecahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cyclene and functionalised cyclenes
Inventor: BOSCHETTI FREDERIC
IPC: C07D487/22
Filed: 2004-06-04
Abstract: Production of 1,4,7,10-tetraaza-cyclododecane (cyclen) (I) from triethylene tetramine (VIII) or ethylene diamine (VIII') involves one-pot preparation of dodecahydro-2a,4a,6a,8a-tetraaza-cyclopenta-(fg)-acenapthylene (IIa) from (VIII) or (VIII'), followed by conversion of (IIa) into (I); or preparation of 8b-methyl-dodecahydro-2a,4a,6a,8a-tetraaza-cyclopenta-(fg)-acenapthylene (IIb) from (VIII) and conversion of (IIb) into (I). Production of 1,4,7,10-tetraaza-cyclododecane (cyclen) of formula (I) from triethylene tetramine of formula NH 2-(CH 2) 2-NH-(CH 2) 2-NH-(CH 2) 2-NH 2(VIII) or ethylene diamine of formula NH 2-(CH 2) 2-NH 2(VIII') involves: (a) one-pot preparation of dodecahydro-2a,4a,6a,8a-tetraaza-cyclopenta-(fg)-acenapthylene of formula (IIa) from (VIII), followed by conversion of (IIa) into (I); (b) preparation of 8b-methyl-dodecahydro-2a,4a,6a,8a-tetraaza-cyclopenta-(fg)-acenapthylene of formula (IIb) from (VIII), followed by conversion of (IIb) into (I); or (c) one-pot preparation of (IIa) from (VIII'), followed by conversion of (IIa) into (I). [Image] Independent claims are included for: (1) the intermediate (IIb) as a new compound; (2) preparation of N-mono-functionalized or N 1,N 7-difunctionalized cyclen derivatives of formula (Va) or (Vb) respectively, by reacting (IIb) with a halo compound of formula R'X (IX) to give (depending on the stoichiometry of the reaction) a mixture of mono-substituted derivatives of formulae (IVa) and (IV'a) or a disubstituted compound of formula (IVb), then subjecting the (IVa)/(IV'a) mixture or (IVb) to alkaline hydrolysis to give (Va) or (Vb) respectively; (3) preparation of bridged cyclen derivatives of formula (VI) by reduction of (IVb); (4) preparation of bridged cyclen derivatives of formula (VII) by hydrogenolysis of (VI); and (5) (IVa), (IV'a), (IVb), (VI) and (VII) as new compounds. [Image] [Image] R' : 1-15C alkyl or -(CH 2) w-Y; w : 1-6 (preferably 1-3); Y : 6-14C aryl (optionally substituted by one or more of halo, 1-4C alkyl, OH, OR 1>, NO 2, NH 2, CONH 2, NHR 2>, CONHR 2>, NR 2>R 3>or CONR 2>R 3>); heteroaryl (preferably containing 1-3 N and 4-12C; and optionally substituted as for aryl); or CN, PO 3H 2, SO 3H, NH 2, CONH 2, NHR 2>1>, CONHR 2>1>, NR 2>1>R 3>1>or CONR 2>1>R 3>1>; R 1>1-4C alkyl, aryl or heteroaryl; R 2>, R 3>1-4C alkyl; R 2>1>, R 3>1>1-4C alkyl or COOR 4>; R 4>H, 1-4C alkyl or aryl (specifically phenyl); X : halogen.
Patent CA-2529747-A1 (CA)
Inventor: ISRAEL MASON A
IPC: H04R29/00
Filed: 2004-06-18
Abstract: A sound focusing mechanism for generating a focused source of sound, which can be used to identify the transmission loss of an object or identify areas of acoustic leakage is disclosed. The sound focusing mechanism includes a housing having at least one wall formed from a material having high sound insulating properties. A sound generating device for generating a sound is located within a central cavity within the housing. An actuator assembly is operatively connected to the sound generating device for selectively operating the sound generating device. The wall is configured to limit the transmission of the sound there through such that a focused beam or pulse sound is emitted from the mechanism through the opening.
Patent CA-2531032-A1 (CA)
Title: Programmed immune responses using a vaccination node
Inventor: JAIN SIDDHARTHA
IPC: A61K/
Filed: 2004-07-09
Abstract: The present invention provides compositions and methods for modulating immune responses to antigens. One aspect of the present invention relates to a particle-based antigen delivery system (vaccination node) that comprises a hydrogel particle capable of both antigen presentation and DC activation. The VN may further comprise a chemoattractant-loaded microsphere capable of attracting DCs to the site of administration. Another aspect of the present invention relates to the use of the VN to modulate antigen presenting cells activation for the prevention and/treatment of various diseases, such as infectious diseases, cancers and autoimmune diseases.
Patent CA-2531429-A1 (CA)
Inventor: MUELLER BARBARA
IPC: A61F13/20
Filed: 2004-07-21
Abstract: The invention relates to dental inlay means used in the oral cavity, characterized in that said means has a cross-sectional surface with a non-circular periphery.
Patent CA-2531493-A1 (CA)
Title: Device and method to facilitate directed delivery and electroporation
Inventor: JAROSZESKI MARK J
IPC: C12N/
Filed: 2004-07-16
Abstract: The present invention provides an apparatus and method that will accomplish molecular delivery and subsequent electroporation with a single apparatus without the need for separate molecule injection and placement of the electroporation applicators.
Patent CA-2532901-A1 (CA)
Inventor: RICHARDSON CHRISTOPHER
IPC: E04B7/18
Filed: 1998-03-09
Abstract: A roof beam for constructing a conservatory roof comprises a glazing bar (10) and upper and lower dcapping (12, 14/50) thereon. The glazing bar has a cross bar (16) having trough formations (26) at each end, whereby there is a recess under the cross bar. The cross bar can, therefore, accommodate both a lower capping (14) for a transom roof beam and a lower capping (50) for a hipped conservatory roof end.
Patent CA-2533376-A1 (CA)
Inventor: TILLMAN JOHN M
IPC: G01R31/08
Filed: 2006-01-20
Abstract: Hot spots in power conductors are monitored by apparatus comprising a temperature probe embedded in an electrically insulative thermally conductive material in surface-to-surface contact with the power conductor, typically at a joint being monitored. The temperature probe is spaced from the power conductor by the electrically insulative thermally conductive material a distance sufficient to provide electrical isolation, while the material has sufficient thermal conductivity that the temperature probe is able to substantiate trends in temperature changes at the joint. The invention can be incorporated into existing electrically insulative supports for the power conductors.
Patent CA-2533632-A1 (CA)
Title: Shoulder joint prosthetic system
Inventor: MESWANIA JAYANTILAL MOHANLAL
IPC: A61F2/40
Filed: 2004-08-31
Abstract: In a first aspect the present invention provides a glenoid prosthesis assembly for use in shoulder joint arthroplasty to address conditions where deterioration of the rotator cuff mechanism of the shoulder joint is severe, the assembly comprising a first shell component (34) to be affixed to a scapula by fixing means, and a smaller second component (35) adapted to nest within the first component and having an articulation surface (36) for articulating with a humeral head, the first component being over-sized relative to the glenoid surface of a scapula whereby the first component may be first affixed to at least two of the glenoid, acromion and coracoid processes of the scapula in use by the fixing means and the second component may be cemented in place within the first component allowing initial adjustability in the poise of the second component relative to the first component.
Patent CA-2535810-A1 (CA)
Title: Tablet containing 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethylester or the salts thereof
Inventor: KOHLRAUSCH ANJA
IPC: A61K31/4439
Filed: 2004-08-10
Abstract: The invention relates to a novel tablet for the active substance 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazolo-5-carbonyl)-pyridino-2-yl-amino]-ethyl propionate and the pharmacologically acceptable salts thereof.
Patent CA-2536247-A1 (CA)
Title: Cellular depolarization and regulation of matrix metalloproteinases
Inventor: MOORE ROBERT M
IPC: A61K31/505
Filed: 2004-08-25
Abstract: A mechanism is disclosed wherein depolarization of the cells associated with disease states, wherein matrix metalloproteinases are implicated as a contributor to the pathology of the disease state, and the subsequent regulation of certain proteins beneficially aids control of the matrix metalloproteinases. This initiating trigger can ultimately result in the down-regulation or up-regulation of matrix metalloproteinases . An example is given wherein matrix metalloproteinase 2 (MMP 2) is down-regulated.
Patent CA-2538840-A1 (CA)
Inventor: NARAYAN OPENDRA
IPC: A61K48/00
Filed: 2004-09-16
Abstract: The present invention is directed to a DNA vaccine for immunization against HIV. The invention comprises a DNA molecule that has a sequence encoding a plurality of viral proteins capable of stimulating an immune response against HIV. The DNA molecule is rendered safe for use as a vaccine by the disruption of genes encoding reverse transcriptase, integrase, and Vif. The DNA molecule is further rendered safe by at least a partial deletion of the 3' LTR.
Patent CA-2544601-A1 (CA)
Title: Modesty panel and external wall execution structure using said modesty panel
Inventor: HONDA TAKASHI
IPC: E04F19/02
Filed: 2006-04-24
Abstract: The present invention provides a modesty panel capable of being stably attached to a fixing surface of a building side regardless of the unevenness of the fixing surface, and an external wall execution structure in which the modesty panel is attached. In the external wall execution structure; a base member 10 provided with an upper attaching portion 12 and a lower attaching portion i3 is fixed to the building external wall surface 2. The base member has first and second engaging stepped portions 16 and 17. To this base member 10, a modesty panel main body 30, provided with first and second engaging ridges 32 and 33, is outwardly engaged. In a superimposed area S formed by the engagement, a fixing screw 4 is screwed to integrally and firmly fix the modesty panel main body 30 and the base member 10.